News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

8,351 stories indexed, page 71 of 140

🇩🇪Oct 10Researchcharite.de

Featured signal

Tracking the impact of mutations

Publisher

Charité - Universitätsmedizin Berlin (EN)

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Charité - Universitätsmedizin Berlin (EN)Original publisher link

Canonical metadata stays public, while full text remains on the original site.

🇺🇸Oct 9Devicesorthopediatrics.com

RESPONSE™ 5.5/6.0

OrthoPediatricsOriginal source

🌍Oct 9Industryevidana.com

Discover the Game-Changer: Elevate Your Play with the Best Wireless Gaming Headset

EvidanaOriginal source

🇺🇸Oct 9CROcelerion.com

Celerion Earns AAHRPP Full Reaccreditation for Five Years, Strengthening Commitment to Ethical Research Practices

CelerionOriginal source

🇩🇪Oct 9CDMOformycon.com

Sehkraft erhalten – Anti-VEGF-Therapien gegen schwere Retinopathien

FormyconOriginal source

🌍Oct 9Industryrss.globenewswire.com

GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress

GH ResearchOriginal source

🌍Oct 8Mediascience37.com

Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial

Science 37Original source

🇫🇷Oct 8CDMOaxplora.com

Axplora initiates global investments exceeding €100m in 2025

NovasepOriginal source

🌍Oct 8Industrymyriad.com

Myriad Genetics’ continued investment in molecular residual disease (MRD) testing drives new patents granted

MyriadOriginal source

🌍Oct 7Regulatoryzamra.co.zm

ZAMRA STRENGTHENS CAPACITY IN THE REGULATION OF BIOSIMILARS

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🇺🇸Oct 7Devicesaccuray.com

Exploring the Impact of Advanced Radiosurgery on Trigeminal Neuralgia

AccurayOriginal source

🇫🇷Oct 7Industrycellectis.com

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

CellectisOriginal source

🇺🇸Oct 7Industrybrukercellularanalysis.com

Introducing the Opto™ CLD with Population Dynamics Kit for Improved Stability Prediction

Berkeley LightsOriginal source

🌍Oct 7Industrycuris.com

Emavusertib in Combination with Gemcitabine and Nab-paclitaxel in Metastatic or Unresectable Pancreatic Ductal Adenocarcinoma AACR 2025 Poster

CurisOriginal source

🌍Oct 7Industryskyebioscience.com

CBeyond P2a Data: Nimacimab as Mono and Combination Therapy

Skye BioscienceOriginal source

🌍Oct 7Regulatoryfifarma.org

62° Consejo Directivo de la OPS: tres declaraciones para avanzar hacia una salud más equitativa y sostenible

FIFARMA NewsOriginal source

🇺🇸Oct 6Industryclinicalink.com

Clinical ink announces selection as finalist for 2025 Prix Galien USA, “Best Digital Health Solution”

Clinical InkOriginal source

🌍Oct 6Industrypowerfulmedical.com

Independent RCT and Late-Breaking Science: PMcardio to Take Center Stage at TCT 2025

Powerful MedicalOriginal source

🌍Oct 6Industrypsomagen.com

WHITE PAPER: Comparison of Illumina and Ultima Sequencing Platforms for 10x Genomics Single-Cell RNA Sequencing

PsomagenOriginal source

🇺🇸Oct 6Industryelementbiosciences.com

Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle Sequencing Workflow for the AVITI System | Element Biosciences

Element BiosciencesOriginal source

🇯🇵Oct 6Devicesolympus-global.com

Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device

Olympus MedicalOriginal source

🇺🇸Oct 6CRObioagilytix.com

The Difference Between Pharmacokinetics and Pharmacodynamics

BioAgilytixOriginal source

🇨🇦Oct 4Researchgenomecanada.ca

AFN resolution on genomic data sovereignty

Genome CanadaOriginal source

🇬🇧Oct 4Researchstemcells.cam.ac.uk

Bertie Göttgens joins Stem Cell Reports as a new Editorial Board member

Cambridge Stem Cell InstituteOriginal source

🇯🇵Oct 3Devicesolympus-global.com

Published Integrated Report 2025

Olympus MedicalOriginal source

🌍Oct 2Industrymyriad.com

Using Prostate Cancer Gene Testing to Guide Treatment Decisions: Insights as We Head into 2026

MyriadOriginal source

🌍Oct 1Industrysubtlemedical.com

Subtle Medical Announces Strong 2025 Growth, Expands Market Leadership in AI Imaging

Subtle MedicalOriginal source

🇺🇸Oct 1Researchpodcasters.spotify.com

Riskgaming State of the Union

Lux CapitalOriginal source

🇯🇵Oct 1Researchmed.kyoto-u.ac.jp

Program-specific Assistant Professor /Program-Specific Researcher (Postdoctoral scholar) Kyoto University, Graduate School of Medicine, Department of Drug Discovery Medicine (Ohtsuki Lab)

Kyoto University Faculty of MedicineOriginal source

🇩🇪Oct 1Researchcharite.de

“We want to provide optimal treatment without delay after a cancer diagnosis”

Charité - Universitätsmedizin Berlin (EN)Original source

🌍Oct 1Industrymyriad.com

Addressing Provider Misconceptions in Ovarian Cancer Genetic Testing

MyriadOriginal source

🌍Oct 1Devicesdigitaldiagnostics.com

AI Doctors Won’t Work For Free

IDx (Digital Diagnostics)Original source

🌍Oct 1Devicesdigitaldiagnostics.com

Autonomous AI Helps SSM Health Improve Eye Screening, Boost Equity

IDx (Digital Diagnostics)Original source

🇯🇵Sep 30Devicesolympus-global.com

Olympus Launches OLYSENSE CAD/AI in the US and Europe

Olympus MedicalOriginal source

🇩🇪Sep 30Researchuk-essen.de

Jürgen Schlebrowski übernimmt Geschäftsführung der Ruhrlandklinik

Universitätsklinikum EssenOriginal source

🇺🇸Sep 30Researchmdanderson.org

Body image after breast cancer surgery

MD Anderson Cancer CenterOriginal source

🌍Sep 30Industryuk-cpi.com

Innovative UK-Brazil-Nigeria partnership to revolutionise cassava farming in Nigeria

CPI (Healthcare Innovation)Original source

🌍Sep 30Industrymeridianbioscience.com

Rethinking Campylobacter: Fast, Accurate Diagnostics for Better GI Outcomes

Meridian BioscienceOriginal source

🇯🇵Sep 30Devicesolympus-global.com

Olympus Commits to Advancing Sustainable Packaging Enabled by DuPont™ Tyvek® with Renewable Attribution

Olympus MedicalOriginal source

🇺🇸Sep 30Industrybrukercellularanalysis.com

Breaking New Ground in Functional Single-Cell Analysis: Meet the 2025 Beacon Discovery Grant Recipients

Berkeley LightsOriginal source

🌍Sep 29Industrymeridianbioscience.com

Understanding H. pylori: Why Timely Testing and Retesting Matters

Meridian BioscienceOriginal source

🌍Sep 29Regulatoryinfarma.pl

KONFERENCJA: (NIE) RÓWNOŚĆ w dostępie do zdrowia – jak stawić czoła barierom i wykluczeniu

INFARMA PolandOriginal source

🇩🇪Sep 29Mediadzne.de

Joint Professorship for Susanne Wegmann at DZNE and Charité

DZNE (Neurodegenerative Diseases)Original source

🇯🇵Sep 26Industryono-pharma.com

社外取締役座談会

Ono Pharmaceutical NewsOriginal source

🇯🇵Sep 26Industryono-pharma.com

COOメッセージ

Ono Pharmaceutical NewsOriginal source

🇯🇵Sep 26Industryono-pharma.com

CEOメッセージ

Ono Pharmaceutical NewsOriginal source

🇯🇵Sep 26Industryono-pharma.com

コーポレートレポートオンライン版2025

Ono Pharmaceutical NewsOriginal source

🌍Sep 26Regulatorycssp.gob.sv

Más de 200 plazas vacantes para Profesionales de la Carrera de Medicina que sean graduados en Ministerio de Salud

Consejo Superior de Salud Pública (El Salvador)Original source

🌍Sep 25Regulatoryaupam.org

إطلاق الاتحاد السوري لمنتجي الأدوية: مكتب إقليمي للاتحاد العربي لتعزيز الأمن الدوائي

Arab Pharma ManufacturersOriginal source

🇺🇸Sep 24Researchpodcasters.spotify.com

The global future of wargaming in Lithuania

Lux CapitalOriginal source

🌍Sep 24Industrysubtlemedical.com

Subtle Medical Named to TIME’s Inaugural List of the World’s Top HealthTech Companies 2025

Subtle MedicalOriginal source

🇺🇸Sep 24Devicesfoundationmedicine.com

Demonstrating the Clinical Utility of Foundation Medicine’s High-Quality Tests and Proprietary Biomarkers - A Research Recap

Foundation MedicineOriginal source

🇺🇸Sep 24CROinvestor.medpace.com

Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025

MedpaceOriginal source

🌍Sep 23Industryzevra.com

Changing The Course of NPC: Long-term Evidence for Disease Modification in a Heterogenous Population

Zevra TherapeuticsOriginal source

🌍Sep 23Industrydayonebio.com

Kids With Brain Tumors Deserve Better

Mersana TherapeuticsOriginal source

🇺🇸Sep 22Researcharchventure.com

ARCH’s Seaport Therapeutics included on Fierce Biotech’s 2025 Fierce 15 list of companies redefining biotech

ARCH Venture PartnersOriginal source

🌍Sep 22Regulatoryaupam.org

مناقشة اولية لملتقى الصناعات الصيدلانية العربية 2026

Arab Pharma ManufacturersOriginal source

🌍Sep 22Mediahealx.ai

Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences

HealxOriginal source

🇺🇸Sep 22Devicesnatus.com

Natus Medical Incorporated

Natus Medical (ArchiMed Group)Original source

🇺🇸Sep 22Industryelementbiosciences.com

Element Biosciences Files Competition and Patent Infringement Countersuits Against Illumina | Element Biosciences

Element BiosciencesOriginal source

Pharmaceutical industry news

Search-friendly hub pages

Regulatory Updates

Clinical Trial Watch

Drug Pipeline

Every signal, indexed and searchable

Latest indexed stories

Tracking the impact of mutations

RESPONSE™ 5.5/6.0

Discover the Game-Changer: Elevate Your Play with the Best Wireless Gaming Headset

Celerion Earns AAHRPP Full Reaccreditation for Five Years, Strengthening Commitment to Ethical Research Practices

Sehkraft erhalten – Anti-VEGF-Therapien gegen schwere Retinopathien

GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress

Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial

Axplora initiates global investments exceeding €100m in 2025

Myriad Genetics’ continued investment in molecular residual disease (MRD) testing drives new patents granted

ZAMRA STRENGTHENS CAPACITY IN THE REGULATION OF BIOSIMILARS

Exploring the Impact of Advanced Radiosurgery on Trigeminal Neuralgia

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

Introducing the Opto™ CLD with Population Dynamics Kit for Improved Stability Prediction

Emavusertib in Combination with Gemcitabine and Nab-paclitaxel in Metastatic or Unresectable Pancreatic Ductal Adenocarcinoma AACR 2025 Poster

CBeyond P2a Data: Nimacimab as Mono and Combination Therapy

62° Consejo Directivo de la OPS: tres declaraciones para avanzar hacia una salud más equitativa y sostenible

Clinical ink announces selection as finalist for 2025 Prix Galien USA, “Best Digital Health Solution”

Independent RCT and Late-Breaking Science: PMcardio to Take Center Stage at TCT 2025

WHITE PAPER: Comparison of Illumina and Ultima Sequencing Platforms for 10x Genomics Single-Cell RNA Sequencing

Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle Sequencing Workflow for the AVITI System | Element Biosciences

Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device

The Difference Between Pharmacokinetics and Pharmacodynamics

AFN resolution on genomic data sovereignty

Bertie Göttgens joins Stem Cell Reports as a new Editorial Board member

Published Integrated Report 2025

Using Prostate Cancer Gene Testing to Guide Treatment Decisions: Insights as We Head into 2026

Subtle Medical Announces Strong 2025 Growth, Expands Market Leadership in AI Imaging

Riskgaming State of the Union

Program-specific Assistant Professor /Program-Specific Researcher (Postdoctoral scholar) Kyoto University, Graduate School of Medicine, Department of Drug Discovery Medicine (Ohtsuki Lab)

“We want to provide optimal treatment without delay after a cancer diagnosis”

Addressing Provider Misconceptions in Ovarian Cancer Genetic Testing

AI Doctors Won’t Work For Free

Autonomous AI Helps SSM Health Improve Eye Screening, Boost Equity

Olympus Launches OLYSENSE CAD/AI in the US and Europe

Jürgen Schlebrowski übernimmt Geschäftsführung der Ruhrlandklinik

Body image after breast cancer surgery

Innovative UK-Brazil-Nigeria partnership to revolutionise cassava farming in Nigeria

Rethinking Campylobacter: Fast, Accurate Diagnostics for Better GI Outcomes

Olympus Commits to Advancing Sustainable Packaging Enabled by DuPont™ Tyvek® with Renewable Attribution

Breaking New Ground in Functional Single-Cell Analysis: Meet the 2025 Beacon Discovery Grant Recipients

Understanding H. pylori: Why Timely Testing and Retesting Matters

KONFERENCJA: (NIE) RÓWNOŚĆ w dostępie do zdrowia – jak stawić czoła barierom i wykluczeniu

Joint Professorship for Susanne Wegmann at DZNE and Charité

社外取締役座談会

COOメッセージ

CEOメッセージ

コーポレートレポート オンライン版2025

Más de 200 plazas vacantes para Profesionales de la Carrera de Medicina que sean graduados en Ministerio de Salud

إطلاق الاتحاد السوري لمنتجي الأدوية: مكتب إقليمي للاتحاد العربي لتعزيز الأمن الدوائي

The global future of wargaming in Lithuania

Subtle Medical Named to TIME’s Inaugural List of the World’s Top HealthTech Companies 2025

Demonstrating the Clinical Utility of Foundation Medicine’s High-Quality Tests and Proprietary Biomarkers - A Research Recap

Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025

Changing The Course of NPC: Long-term Evidence for Disease Modification in a Heterogenous Population

Kids With Brain Tumors Deserve Better

ARCH’s Seaport Therapeutics included on Fierce Biotech’s 2025 Fierce 15 list of companies redefining biotech

مناقشة اولية لملتقى الصناعات الصيدلانية العربية 2026

Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences

Natus Medical Incorporated

Element Biosciences Files Competition and Patent Infringement Countersuits Against Illumina | Element Biosciences

コーポレートレポートオンライン版2025